The AF symposium has announced two late-breaking clinical trial sessions set to be presented in Boston from February 1st to February 3rd this year. The AF symposium is dedicated to bringing together the world’s leading scientists to share the latest advances in atrial fibrillation.
Thursday 1st February 2024
Late Breaking Clinical Science Session I
6:00 – 7:00pm
Acute Kidney Injury Resulting From Hemoglobinuria Following Pulsed-Field Ablation In Atrial Fibrillation: Is It Preventable? - Presented by Dr Andrea Natale, MD.
Real-world Data Affirms Safety and Effectiveness of Low/Zero Fluoroscopy Atrial Fibrillation Ablation - Presented by Dr Jose Osorio, MD.
Impact of Left Atrial Posterior Wall Ablation During Pulsed Field Ablation for Persistent Atrial Fibrillation: A MANIFEST-PF Registry Sub-Study - Presented by Dr Mohit Turagam, MD.
Safety, Efficiency, and Accuracy of Pre-procedural Predictive Modeling Using Artificial Intelligence Algorithm to Predict the Left Atrial Appendage Characteristics and the Appropriate Device Size for Closure - Presented by Dr Devi Nair, MD.
Friday 2nd February 2024
Late Breaking Clinical Science Session II
5:00 – 6:45pm
First Experience with the Amulet Occluder in the United States: Early Insights from EMERGE LAA Post-Approval Study - Presented by Dr Christopher R. Ellis, MD.
Pulmonary Vein Narrowing after Pulsed Field vs Thermal Ablation: A Prespecified Secondary Endpoint of the Randomized ADVENT Trial - Presented by Dr Moussa Mansour, MD.
Pulsed Field Ablation Using a Variable Loop Circular Catheter with 3D Mapping Integration: Early Outcomes of the admIRE Study - Presented by Dr David Newton, MD.
Predictors of Success for Pulmonary Vein Isolation with Pulsed Field Ablation Using a Variable Loop Catheter with 3D Mapping Integration: Complete 12-month outcomes from inspire - Presented by Dr Vivek Reddy, MD.
Long-Term Effects of Pulsed Field Ablation on Coronary Arteries - Presented by Dr Yury Malyshev, MD.
Left Atrial Appendage Exclusion in Addition to Pulmonary Vein Isolation for
Non-paroxysmal Atrial Fibrillation: Results from the aMAZE Continued Access Protocol (aMAZE CAP) - Presented by Dr Dhanunjaya Lakkireddy, MD, MBA.